Kim Lorence H.
Director at RVMD; Chief Financial Officer at MRNA
- Sold, on record
- $86.5M
- Dollars the filings state
- Form 4 sales
- 14
- Latest Sep 8, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale MRNAPlan not statedMar 16, 2020 2020
Sold 20,000 shares at $26.19 ($524k)
Kim Lorence H., Chief Financial Officer
Sold 1.6% of holdings ($33.1M position)1.2M shares left0.9x usual sizeFiling
- 2 Form 4 sale MRNAPlan not statedApr 15, 2020 +30 days
Sold 20,000 shares at $36.21 ($724k)
Kim Lorence H., Chief Financial Officer
Sold 1.6% of holdings ($45M position)1.2M shares left1x usual sizeFiling
- 3 Form 4 sale MRNAUnusualMay 12, 2020 +27 days
Sold 241,000 shares at $64.49 ($15.5M)
Kim Lorence H., Chief Financial Officer
Sold 16.5% of holdings ($94.4M position)1.2M shares left12.1x usual sizeFiling
- 4 Form 4 sale MRNAUnusualMay 18, 2020 +6 days
Sold 261,000 shares at $80.85 ($21.1M)
Kim Lorence H., Chief Financial Officer
Sold 17.8% of holdings ($118M position)1.2M shares left13.1x usual sizeFiling
- 5 Form 4 sale MRNAUnusualMay 27, 2020 +9 days
Sold 241,000 shares at $51.13 ($12.3M)
Kim Lorence H., Chief Financial Officer
Sold 16.7% of holdings ($73.8M position)1.2M shares left10.8x usual sizeFiling
- 6 Form 4 sale MRNAUnusualJun 2, 2020 +6 days
Sold 241,000 shares at $58.30 ($14.1M)
Kim Lorence H., Chief Financial Officer
Sold 16.7% of holdings ($84.2M position)1.2M shares left9.8x usual sizeFiling
- 7 Form 4 sale RVMDRoutineAug 31, 2026 +2281 days
Sold 56,000 shares at $203.24 ($11.4M)
Kim Lorence H., Director
10b5-1 planSold 76.6% of holdings ($14.9M position)17,090 shares leftFirst sale on recordFiling
- 8 Form 4 sale RVMDRoutineSep 8, 2026 +8 days
Sold 17,090 shares at $209.82 ($3.6M)
Kim Lorence H., Director
10b5-1 planSold 100% of holdings ($3.6M position)0 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (14)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Sep 10, 2026 | RVMD | Director | Form 4 sale | 17,090 | $3.6M | 100.0% | Routine | SEC |
| Aug 31, 2026 | Sep 2, 2026 | RVMD | Director | Form 4 sale | 56,000 | $11.4M | 76.6% | Routine | SEC |
| Jun 2, 2020 | Jun 4, 2020 | MRNA | Chief Financial Officer | Form 4 sale | 241,000 | $14.1M | 16.7% | Unusual | SEC |
| May 27, 2020 | May 28, 2020 | MRNA | Chief Financial Officer | Form 4 sale | 241,000 | $12.3M | 16.7% | Unusual | SEC |
| May 18, 2020 | May 19, 2020 | MRNA | Chief Financial Officer | Form 4 sale | 261,000 | $21.1M | 17.8% | Unusual | SEC |
| May 12, 2020 | May 14, 2020 | MRNA | Chief Financial Officer | Form 4 sale | 241,000 | $15.5M | 16.5% | Unusual | SEC |
| Apr 15, 2020 | Apr 16, 2020 | MRNA | Chief Financial Officer | Form 4 sale | 20,000 | $724k | 1.6% | Plan not stated | SEC |
| Mar 16, 2020 | Mar 18, 2020 | MRNA | Chief Financial Officer | Form 4 sale | 20,000 | $524k | 1.6% | Plan not stated | SEC |
| Mar 4, 2020 | Mar 6, 2020 | MRNA | Chief Financial Officer | Form 4 sale | 20,000 | $554k | 1.6% | Plan not stated | SEC |
| Feb 26, 2020 | Feb 27, 2020 | MRNA | Chief Financial Officer | Form 4 sale | 20,000 | $568k | 1.5% | Plan not stated | SEC |
| Feb 7, 2020 | Feb 11, 2020 | MRNA | Chief Financial Officer | Form 4 sale | 33,295 | $768k | 2.5% | Plan not stated | SEC |
| Jan 28, 2020 | Jan 29, 2020 | MRNA | Chief Financial Officer | Form 4 sale | 24,705 | $569k | 1.8% | Plan not stated | SEC |
| Jan 22, 2020 | Jan 23, 2020 | MRNA | Chief Financial Officer | Form 4 sale | 2,000 | $46k | 0.1% | Plan not stated | SEC |
| Dec 6, 2019 | Dec 9, 2019 | MRNA | Chief Financial Officer | Form 4 sale | 238,532 | $4.8M | 14.9% | Plan not stated | SEC |